Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q3)Nov 1, 2025 | (Q2)Aug 2, 2025 | (Q1)May 3, 2025 | (FY)Feb 1, 2025 | (Q4)Feb 1, 2025 | (Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -40.36%10.02M | 44.22%59.13M | -1,388.31%-46.85M | 49.95%104.26M | 27.20%49.6M | 12.63%16.8M | 10.21%41M | 85.42%-3.15M | 69.53M | 39M |
| Net income from continuing operations | -58.18%864K | -16.39%13.14M | -577.21%-10.02M | -18.06%12.14M | -31,969.23%-4.17M | -60.89%2.07M | 17.45%15.72M | 61.48%-1.48M | --14.82M | ---13K |
| Operating gains losses | -240.15%-2.23M | 49.98%-1.15M | 176.35%1.16M | -1,147.91%-8.36M | -2,139.31%-3.87M | 76.32%-655K | -250.36%-2.31M | -306.79%-1.52M | ---670K | ---173K |
| Depreciation and amortization | 8.54%14.5M | 8.96%14.45M | 4.74%14.11M | 10.77%53.74M | -1.01%13.65M | 12.91%13.35M | 14.86%13.27M | 18.69%13.47M | --48.52M | --13.79M |
| Remuneration paid in stock | -33.97%103K | 33.33%152K | 198.28%346K | -10.88%516K | 26.21%130K | 54.46%156K | 72.73%114K | -62.46%116K | --579K | --103K |
| Deferred tax | -42.75%375K | -12.75%5.01M | -495.50%-3.84M | -29.34%3.76M | -731.80%-1.99M | -68.57%655K | 26.05%5.74M | 40.04%-644K | --5.32M | ---239K |
| Other non cashItems | 25.96%1.18M | 75.88%1.34M | 12.68%1.51M | 31.01%2.8M | -154.34%-244K | 59.73%936K | 74.20%763K | 101.65%1.34M | --2.14M | --449K |
| Change In working capital | -391.18%-5.85M | 304.35%25.26M | -223.95%-51.27M | 793.43%34.19M | 87.27%44.96M | 64.87%-1.19M | 36.99%6.25M | 47.44%-15.83M | ---4.93M | --24.01M |
| -Change in receivables | 19.46%-327K | 326.76%322K | 20.04%-2.14M | -2,277.78%-2.74M | -13.69%479K | -114.81%-406K | -133.33%-142K | -301.65%-2.68M | --126K | --555K |
| -Change in inventory | 11.54%-3.34M | 187.72%8.7M | 62.64%-2.09M | -153.52%-10.85M | -67.43%8.43M | -514.85%-3.77M | -1.60%-9.92M | -272.11%-5.59M | --20.28M | --25.88M |
| -Change in prepaid assets | 136.93%5M | 29.70%-729K | -142.19%-5.13M | 297.23%3.63M | 1,030.48%4.67M | 45.86%2.11M | -181.14%-1.04M | 47.85%-2.12M | ---1.84M | ---502K |
| -Change in payables and accrued expense | -634.62%-6.9M | -0.60%17.64M | -1,054.06%-40.92M | 309.31%42.99M | 1,258.91%27.5M | 129.06%1.29M | 36.03%17.75M | 86.75%-3.55M | ---20.54M | ---2.37M |
| -Change in other current assets | ---- | --0 | --0 | ---- | ---- | ---- | 101.21%11K | -207.14%-15K | ---- | ---- |
| -Change in other working capital | 30.70%-289K | -61.89%-667K | 47.45%-988K | 139.61%1.17M | 763.11%3.88M | 62.63%-417K | -185.48%-412K | -0.16%-1.88M | ---2.96M | --450K |
| Interest received (cash flow from operating activities) | -26.92%1.08M | -36.71%919K | -15.66%1.26M | 25.31%5.98M | 3.95%1.55M | 24.12%1.48M | 30.34%1.45M | 53.86%1.49M | --4.77M | --1.49M |
| Tax refund paid | --0 | --0 | -20.62%-117K | 49.26%-516K | 1.41%-419K | --0 | --0 | 83.61%-97K | ---1.02M | ---425K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -40.36%10.02M | 44.22%59.13M | -1,388.31%-46.85M | 49.95%104.26M | 27.20%49.6M | 12.63%16.8M | 10.21%41M | 85.42%-3.15M | --69.53M | --39M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -52.57%-10.68M | -23.36%-8.34M | -89.24%-11.93M | -76.21%-31.19M | -25.91%-11.12M | -108.95%-7M | -229.31%-6.76M | -82.06%-6.3M | -17.7M | -8.84M |
| Net PPE purchase and sale | -52.57%-10.68M | -23.36%-8.34M | -89.24%-11.93M | -76.21%-31.19M | -25.91%-11.12M | -108.95%-7M | -229.31%-6.76M | -82.06%-6.3M | ---17.7M | ---8.84M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -52.57%-10.68M | -23.36%-8.34M | -89.24%-11.93M | -76.21%-31.19M | -25.91%-11.12M | -108.95%-7M | -229.31%-6.76M | -82.06%-6.3M | ---17.7M | ---8.84M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 34.56%-7.47M | -5.50%-12.06M | -43.26%-14.09M | -0.32%-40.03M | 50.69%-7.35M | -16.39%-11.42M | -81.84%-11.43M | -10.45%-9.83M | -39.9M | -14.9M |
| Net issuance payments of debt | 36.57%-7.3M | -4.43%-12.01M | -55.11%-15.28M | 7.15%-40.25M | 50.39%-7.39M | -17.33%-11.51M | -17.79%-11.5M | -10.99%-9.85M | ---43.35M | ---14.9M |
| Net common stock issuance | -285.87%-171K | -158.67%-44K | 7,820.00%1.19M | -64.70%227K | --45K | --92K | -88.34%75K | --15K | --643K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.81M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 34.56%-7.47M | -5.50%-12.06M | -43.26%-14.09M | -0.32%-40.03M | 50.69%-7.35M | -16.39%-11.42M | -81.84%-11.43M | -10.45%-9.83M | ---39.9M | ---14.9M |
| Net cash flow | ||||||||||
| Beginning cash position | 1.01%125.29M | -13.64%85.43M | 35.54%158.12M | 13.25%116.65M | 21.52%123.07M | 28.30%124.04M | 42.54%98.92M | 13.25%116.65M | --103M | --101.28M |
| Current changes in cash | -403.03%-8.13M | 69.81%38.73M | -277.86%-72.87M | 177.04%33.04M | 104.03%31.13M | -191.98%-1.62M | -20.98%22.81M | 43.20%-19.28M | --11.93M | --15.26M |
| Effect of exchange rate changes | 243.19%2.24M | -50.93%1.14M | -88.57%177K | 388.75%8.43M | 3,160.00%3.91M | -76.97%653K | 246.86%2.31M | 351.31%1.55M | --1.72M | --120K |
| End cash Position | -2.99%119.4M | 1.01%125.29M | -13.64%85.43M | 35.54%158.12M | 35.54%158.12M | 21.52%123.07M | 28.30%124.04M | 42.54%98.92M | --116.65M | --116.65M |
| Free cash from | -106.75%-662K | 48.35%50.79M | -521.94%-58.78M | 40.98%73.06M | 27.58%38.48M | -15.27%9.8M | -2.59%34.23M | 62.27%-9.45M | --51.83M | --30.16M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.